Literature DB >> 2031690

The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users.

S Darke1, W Hall, N Heather, J Ward, A Wodak.   

Abstract

The initiation and maintenance of substantial behaviour change is required to reduce the spread of HIV infection among the intravenous drug-using population. In order to ascertain the efficacy of interventions aimed at reducing HIV-related risk-taking behaviour among this population, valid and reliable (yet preferably short) instruments for measuring such behaviour are required. The HIV risk-taking behaviour scale (HRBS) is a brief 11-item interviewer-administered scale which examines the behaviour of intravenous drug users in relation to both injecting and sexual behaviour. This paper describes the construction of the scale, in addition to data evaluating its reliability and validity. Initial analyses indicate that the scale has satisfactory psychometric properties.

Entities:  

Mesh:

Year:  1991        PMID: 2031690     DOI: 10.1097/00002030-199102000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  109 in total

1.  Drug-related behaviors independently associated with syphilis infection among female sex workers in two Mexico-US border cities.

Authors:  Oralia Loza; Thomas L Patterson; Melanie Rusch; Gustavo A Martínez; Remedios Lozada; Hugo Staines-Orozco; Carlos Magis-Rodríguez; Steffanie A Strathdee
Journal:  Addiction       Date:  2010-04-27       Impact factor: 6.526

2.  Gender differences in the rates and correlates of HIV risk behaviors among drug abusers.

Authors:  Audrey Brooks; Christina S Meade; Jennifer Sharpe Potter; Yuliya Lokhnygina; Donald A Calsyn; Shelly F Greenfield
Journal:  Subst Use Misuse       Date:  2010-06-10       Impact factor: 2.164

Review 3.  The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.

Authors:  Michelle Gillies; Norah Palmateer; Sharon Hutchinson; Syed Ahmed; Avril Taylor; David Goldberg
Journal:  BMC Public Health       Date:  2010-11-23       Impact factor: 3.295

4.  The Short Inventory of Problems - revised (SIP-R): psychometric properties within a large, diverse sample of substance use disorder treatment seekers.

Authors:  Brian D Kiluk; Jessica A Dreifuss; Roger D Weiss; Jon Morgenstern; Kathleen M Carroll
Journal:  Psychol Addict Behav       Date:  2012-05-28

5.  The moderating effects of cannabis use and decision making on the relationship between conduct disorder and risky sexual behavior.

Authors:  J Megan Ross; Stefany Coxe; Randi M Schuster; Angelica Rojas; Raul Gonzalez
Journal:  J Clin Exp Neuropsychol       Date:  2015-04-01       Impact factor: 2.475

6.  Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers.

Authors:  Kelly E Dunn; Kathryn A Saulsgiver; Mollie E Patrick; Sarah H Heil; Stephen T Higgins; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2013-08-30       Impact factor: 4.492

7.  The impact of childhood abuse on inpatient substance users: specific links with risky sex, aggression, and emotion dysregulation.

Authors:  Anne N Banducci; Elana M Hoffman; C W Lejuez; Karestan C Koenen
Journal:  Child Abuse Negl       Date:  2014-02-09

8.  Initial feasibility and validity of a prospective memory training program in a substance use treatment population.

Authors:  Mary M Sweeney; Olga Rass; Patrick S Johnson; Eric C Strain; Meredith S Berry; Hoa T Vo; Marc J Fishman; Cynthia A Munro; George W Rebok; Miriam Z Mintzer; Matthew W Johnson
Journal:  Exp Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.157

9.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.

Authors:  Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

10.  Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial.

Authors:  Peter Roy-Byrne; Kristin Bumgardner; Antoinette Krupski; Chris Dunn; Richard Ries; Dennis Donovan; Imara I West; Charles Maynard; David C Atkins; Meredith C Graves; Jutta M Joesch; Gary A Zarkin
Journal:  JAMA       Date:  2014-08-06       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.